Cited 0 times in
혈전용해술 후 재폐색과 뇌출혈
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 남효석 | - |
dc.contributor.author | 이종윤 | - |
dc.contributor.author | 허지회 | - |
dc.date.accessioned | 2017-05-04T07:40:03Z | - |
dc.date.available | 2017-05-04T07:40:03Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 1738-1428 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/147621 | - |
dc.description.abstract | In patients with acute ischemic stroke, early treatment with thrombolytic agents is thought to permit reperfusion to ischemic but still viable brain areas and to promote recovery of function. However, reocclusion and hemorrhagic transformation may occur after thrombolysis and these are major factors of no-improvement or deterioration despite the initial successful recanalization. Reocclusion occurs frequently during or immediately after successful recanalization, often silently. In the case of reocclusion, initial platelet-fibrin thrombi are converted into platelet-rich thrombi by platelet-mediated thrombotic mechanisms. Therefore, if can be effectively resolved by use of the platelet membrane glycoprotein Iib/IIIa receptor inhibitors such as abciximab. Hemorrhagic transformation (HT) is a well-known factor limiting the use of thrombolytics and negating the effect of the treatment. Recent studies demonstrate that loss of integrity of the blood-brain barrier in association with active proteolytic degradation of vascular extracellular matrix is a key molecular pathway leading to HT. Therapeutic strategies to prevent reocclusion and HT by use of agents that act against these mechanisms before or during thrombolysis are warranted to enhance the efficacy of reperfusion therapy in stroke. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 295~302 | - |
dc.language | Korean | - |
dc.publisher | Korean Neurological Association | - |
dc.relation.isPartOf | Journal of the Korean Neurological Association | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Thrombolytic therapy | - |
dc.subject.MESH | Reocclusion | - |
dc.subject.MESH | Hemorrhagic transformation | - |
dc.subject.MESH | Cerebral infarction | - |
dc.title | 혈전용해술 후 재폐색과 뇌출혈 | - |
dc.title.alternative | Reocclusion and Hemorrhagic Transformation following Thrombolytic Therapy | - |
dc.type | Article | - |
dc.publisher.location | Korea | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Neurology (신경과학교실) | - |
dc.contributor.department | Dept. of Neurology (신경과학교실) | - |
dc.contributor.department | Dept. of Neurology (신경과학교실) | - |
dc.contributor.googleauthor | 이종윤 | - |
dc.contributor.googleauthor | 남효석 | - |
dc.contributor.googleauthor | 허지회 | - |
dc.identifier.doi | OAK-2005-03370 | - |
dc.contributor.localId | A01273 | - |
dc.contributor.localId | A03145 | - |
dc.contributor.localId | A04369 | - |
dc.relation.journalcode | J01835 | - |
dc.relation.journalsince | 2004~ | - |
dc.relation.journalbefore | ~2003 Journal of the Korean Neurological Association (대한신경과학회지) | - |
dc.subject.keyword | Thrombolytic therapy | - |
dc.subject.keyword | Reocclusion | - |
dc.subject.keyword | Hemorrhagic transformation | - |
dc.subject.keyword | Cerebral infarction | - |
dc.contributor.alternativeName | Nam, Hyo Suk | - |
dc.contributor.alternativeName | Lee, Jong Yun | - |
dc.contributor.alternativeName | Heo, Ji Hoe | - |
dc.citation.volume | 23 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 295 | - |
dc.citation.endPage | 302 | - |
dc.identifier.bibliographicCitation | Journal of the Korean Neurological Association, Vol.23(3) : 295-302, 2005 | - |
dc.date.modified | 2017-05-04 | - |
dc.identifier.rimsid | 40393 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.